Emotional effects of stem cell donation on haploidentical donors
Part of Mental health clinical trials.
This study looks at the emotional and psychological impact on people who donate stem cells to a family member (a haploidentical donor). It aims to understand how the donation experience affects donors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a haploidentical (half-matched) stem cell donor for a family member
- You are either a parent or a child of the person receiving the stem cells
- You live in mainland France and are being cared for at one of the study centers
- You have French health insurance (Social Security)
- You can read and write in French
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks how children who had a stem cell transplant for a primary immune deficiency are doing emotionally and mentally, at least 2 years after the transplant. It helps us understand the long-term effects of this treatment on children's health and development.
This study looks at how donating stem cells affects the health of both related and unrelated donors over time. It helps doctors better understand the long-term effects of donation.
This study looks at how patients with sickle cell disease who had a stem cell transplant from a sibling are doing now, compared to patients who didn't have a transplant. It focuses on health status and quality of life over the long term.
This study compares outcomes in patients receiving stem cell transplants from either a sibling or a cousin donor. It looks at the transplant process to help doctors understand which type of donor might lead to better results for people with blood cancers.
This study compares a newer type of stem cell transplant (using special cells) to the standard method for children who need a half-matched donor. It aims to see if the new approach is safer and works as well.
This study looks at how a genetic risk factor in a stem cell donor (called CHIP) may affect outcomes after an allogeneic (donor-to-recipient) stem cell transplant. It may help doctors better predict which donor factors are important for patient outcomes.
Hear when a new Transplantation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.